Benjamin Rossi
Stock Analyst at JP Morgan
(2.58)
# 2,138
Out of 5,124 analysts
17
Total ratings
75%
Success rate
10.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Rossi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Reinstates: Overweight | $44 | $39.51 | +11.36% | 1 | Dec 17, 2025 | |
| USPH U.S. Physical Therapy | Maintains: Overweight | $110 → $100 | $78.88 | +26.77% | 2 | Nov 24, 2025 | |
| SGRY Surgery Partners | Maintains: Neutral | $27 → $20 | $15.26 | +31.06% | 2 | Nov 24, 2025 | |
| ARDT Ardent Health | Maintains: Neutral | $15 → $12 | $8.64 | +38.89% | 3 | Nov 24, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $200 → $230 | $199.45 | +15.32% | 3 | Nov 13, 2025 | |
| INNV InnovAge Holding | Assumes: Underweight | $5 | $5.19 | -3.66% | 1 | Sep 18, 2025 | |
| CON Concentra Group Holdings Parent | Assumes: Overweight | $31 | $19.41 | +59.71% | 1 | Sep 18, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $215 → $195 | $219.88 | -11.32% | 2 | Aug 4, 2025 | |
| HCA HCA Healthcare | Maintains: Neutral | $360 → $370 | $470.39 | -21.34% | 2 | Aug 4, 2025 |
PACS Group
Dec 17, 2025
Reinstates: Overweight
Price Target: $44
Current: $39.51
Upside: +11.36%
U.S. Physical Therapy
Nov 24, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $78.88
Upside: +26.77%
Surgery Partners
Nov 24, 2025
Maintains: Neutral
Price Target: $27 → $20
Current: $15.26
Upside: +31.06%
Ardent Health
Nov 24, 2025
Maintains: Neutral
Price Target: $15 → $12
Current: $8.64
Upside: +38.89%
Tenet Healthcare
Nov 13, 2025
Maintains: Overweight
Price Target: $200 → $230
Current: $199.45
Upside: +15.32%
InnovAge Holding
Sep 18, 2025
Assumes: Underweight
Price Target: $5
Current: $5.19
Upside: -3.66%
Concentra Group Holdings Parent
Sep 18, 2025
Assumes: Overweight
Price Target: $31
Current: $19.41
Upside: +59.71%
Universal Health Services
Aug 4, 2025
Maintains: Neutral
Price Target: $215 → $195
Current: $219.88
Upside: -11.32%
HCA Healthcare
Aug 4, 2025
Maintains: Neutral
Price Target: $360 → $370
Current: $470.39
Upside: -21.34%